Treatment

Recommended Phase II Dose clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1, PHASE2
Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC
This study looks at combining two drugs, bexmarilimab and nivolumab, for advanced skin and lung cancers. It aims to find a safe dose and see if this combination can help when previous immunotherapy stopped working.
For: Melanoma (Skin Cancer) · Non Small Cell Lung Cancer · Solid Tumor in Advanced Stage
United Kingdom